C12Y 304/22041
Cathepsin f
Official title: Cathepsin F (3.4.22.41)
C12Y304/22041 (Cathepsin f) appears on 4 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 4
- Assignees
- 2
- Inventors
- 4
- Latest grant
- 26 Feb 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 1 | 2 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
By publication year.
Recent patents
- Treatment of synucleinopathies26 Feb 2019US 10,213,494 B2Genzyme Corporation
- Treatment of synucleinopathies19 Apr 2016US 9,314,512 B2The Brigham and Women S Hospital, Inc.
- Treatment of synucleinopathies11 Aug 2015US 9,101,623 B2The Brigham and Women S Hospital, Inc.
- Treatment of synucleinopathies4 Jun 2013US 8,454,954 B2The Brigham and Women S Hospital, Inc.
- Treatment of Synucleinopathies14 Jul 2016US 2016/0199461 A1Genzyme Corporation
- Treatment of synucleinopathies3 Mar 2016US 2016/0058849 A1The Brigham and Women S Hospital, Inc.
- Treatment of Synucleinopathies11 Jul 2013US 2013/0177549 A1The Brigham and Women S Hospital, Inc.
- Treatment of synucleinopathies17 Feb 2011US 2011/0038851 A1The Brigham and Women S Hospital, Inc.
Most cited
By later US patents